SYK · 10-Q · 2026Q3 · Full report
Supply Chain Constraints
STRYKER CORP · 2026-10-30 · Importance 52 · Surprise 42 · Matches filing data
Stryker reported that Peripheral Vascular operating results were affected by near-term operational and supply constraints and a longer expected period to achieve anticipated growth and market recovery. The company’s updated projections considered supply constraints and the competitive environment, and it performed an interim impairment assessment of the Peripheral Vascular reporting unit. The filing does not quantify the supply constraints’ effect on sales or describe specific component shortages, lead times, or supplier diversification actions.
Key facts
- Stryker reported a $293 million impairment charge for the Peripheral Vascular reporting unit after updated projections reflected near-term operational and supply constraints and a longer expected period to achieve anticipated growth and market recovery. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| operating_income | negative | realized | -4.5% | Stryker reported a $293 million impairment charge for the Peripheral Vascular reporting unit after updated projections reflected near-term… |
| assets | negative | realized | -0.6% | Stryker reported a $293 million impairment charge for the Peripheral Vascular reporting unit after updated projections reflected near-term… |